glp-1 drugs and addiction The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders GLP-1 and Addiction: Clinical Trials

In the New England Journal of Medicine a double-blind randomized trial of 156 participants with early Parkinsons disease were assigned to lixisenatide or placebo

doi: 10.3389/fnagi.2022.804890 356 WaxmanS

Contraindicated in glutathione-sensitive patients

What to tell your healthcare professional: When discussing CoQ10 or any supplement, provide complete information including: The specific product name, dose, and how long you have been taking it Your reasons for wanting to take CoQ10 Any other medications, supplements, or herbal remedies you are using Any relevant medical conditions Whether you are exclusively breastfeeding or combination feeding Your GP or pharmacist can provide personalised advice based on your individual health status and help you weigh the potential benefits against the uncertainties

Sekhar RV, et al

Meskipun tersedia dalam berbagai bentuk, penting untuk bijak dalam penggunaannya